Use of Tobacco Marketing Descriptors to Convey Modified Risk; Request for Comments, 2879 [2010-784]
Download as PDF
Federal Register / Vol. 75, No. 11 / Tuesday, January 19, 2010 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2010–N–0020]
Use of Tobacco Marketing Descriptors
to Convey Modified Risk; Request for
Comments
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice; request for comments.
SUMMARY: The Food and Drug
Administration (FDA) is establishing a
public docket to provide an opportunity
for interested parties to share
information, research, and ideas on
tobacco product marketing descriptors
that may be considered similar to the
prohibited terms ‘‘light,’’ ‘‘mild,’’ and
‘‘low.’’ This information will be used to
further FDA’s efforts to reduce
misleading and deceptive advertising
practices.
DATES: Submit electronic or written
comments by February 18, 2010.
ADDRESSES: Submit electronic
comments to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT:
Kathleen K. Quinn, Center for Tobacco
Products, Food and Drug
Administration, 9200 Corporate Blvd.,
Rockville, MD 20850–3229, 240–276–
1717, Kathleen.Quinn@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
jlentini on DSKJ8SOYB1PROD with NOTICES
I. Background
Tobacco products are responsible for
more than 440,000 deaths each year.
The Centers for Disease Control and
Prevention report that 70 percent of the
46 million adults who currently smoke
in the United States want to quit. Since
the introduction to the American market
in the 1960s of cigarettes marketed as
‘‘light,’’ ‘‘low,’’ or ‘‘mild,’’ millions of
smokers have turned to these products
in the false belief that they pose fewer
health hazards and may facilitate
quitting. While scientific evidence has
demonstrated that light cigarettes do not
reduce the health risks associated with
smoking, sales of light cigarettes have
continued to climb, accounting for 92.7
percent of cigarettes sold in the United
States in 2006. Curbing the significant
adverse consequences of tobacco use is
one of the most important public health
goals of our time. One step toward the
realization of that goal is to prevent
misleading labeling claims and to
VerDate Nov<24>2008
16:28 Jan 15, 2010
Jkt 220001
regulate ‘‘modified risk’’ tobacco
products.
On June 22, 2009, the President
signed the Family Smoking Prevention
and Tobacco Control Act (the Tobacco
Control Act) into law. The Tobacco
Control Act granted FDA important new
authority to regulate the manufacture,
marketing, and distribution of tobacco
products to protect the public health
generally and to reduce tobacco use by
minors. Among its many provisions, the
Tobacco Control Act added section
911(b) to the Federal Food, Drug, and
Cosmetic Act (the act), banning the
manufacture of any tobacco product ‘‘the
label, labeling, or advertising of which
uses the descriptors ‘light’, ‘mild’, or
‘low’ or similar descriptors;’’ as of June
22, 2010.
We are requesting comments that will
inform the agency’s development of
guidance on the meaning of the term
‘‘similar descriptors.’’ A copy of the
Tobacco Control Act is available at
https://www.fda.gov/tobacco.
II. Request for Comments and
Information
Product packaging plays a critical role
in fostering brand loyalty and
communicating messages to consumers
about the risks and benefits of product
use. FDA is aware that messages of
reduced harm can be conveyed through
a variety of visual cues. We are therefore
requesting comment on ways in which
descriptors that may be considered
similar to ‘‘light,’’ ‘‘mild’’ and ‘‘low’’ used
on tobacco product packaging could
impact consumer perceptions of risk.
Such descriptors may include:
• Adjectives like ‘‘silver,’’ ‘‘fine,’’ or
‘‘smooth;’’
• Colors like white, silver or pastels;
• Printed numbers associated with
risk level;
• Letters (e.g., ‘‘L’’) or other symbols
that connote ‘‘light;’’
• Depiction of filters or other images
that imply purification or healthfulness;
• Words used in brand names that
have associations with potency, risk, or
healthfulness; and
• Use of terms such as ‘‘natural’’ and
‘‘no additives.’’
The agency will consider information
submitted to the docket in developing
guidance on the meaning of the term
‘‘similar descriptors’’ as it pertains to the
label, labeling, or advertising of
modified risk tobacco products.
III. Comments
Interested persons may submit to the
Division of Dockets Management (see
ADDRESSES) electronic or written
comments regarding this document.
Submit a single copy of electronic
PO 00000
Frm 00036
Fmt 4703
Sfmt 4703
2879
comments or two paper copies of any
mailed comments, except that
individuals may submit one paper copy.
Comments are to be identified by the
docket number found in brackets in the
heading of this document. Received
comments may be seen in the Division
of Dockets Management between 9 a.m.
and 4 p.m., Monday through Friday.
Dated: January 12, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy,
Planning and Budget.
[FR Doc. 2010–784 Filed 1–15–10; 8:45 am]
BILLING CODE 4160–01–S
DEPARTMENT OF HOMELAND
SECURITY
[Docket No. DHS–2009–0162]
RIN 1601–ZA08
Identification of Foreign Countries
Whose Nationals Are Eligible To
Participate in the H–2A and H–2B Visa
Programs
Office of the Secretary, DHS.
Notice.
AGENCY:
ACTION:
SUMMARY: Under Department of
Homeland Security (DHS) regulations,
U.S. Citizenship and Immigration
Services (USCIS) may only approve
petitions for H–2A and H–2B
nonimmigrant status for nationals of
countries that the Secretary of
Homeland Security, with the
concurrence of the Secretary of State,
has designated by notice published in
the Federal Register. That notice must
be renewed each year. This notice
announces that the Secretary of
Homeland Security, in consultation
with the Secretary of State, is
identifying 39 countries whose
nationals are eligible to participate in
the H–2A and H–2B programs for the
coming year.
DATES: Effective Date: This notice is
effective January 18, 2010, and shall be
without effect at the end of one year
after January 18, 2010.
FOR FURTHER INFORMATION CONTACT: Alex
Hartman, DHS Office of Policy,
Department of Homeland Security,
Washington, DC 20528 (202) 282–9820.
SUPPLEMENTARY INFORMATION:
Background: Pursuant to 8 CFR
214.2(h)(5)(i)(F)(1)(i) and 8 CFR
214.2(h)(6)(i)(E)(1), USCIS may only
approve H–2A and H–2B petitions for
nationals of countries that the Secretary
of Homeland Security, with the
concurrence of the Secretary of State,
has designated as participating
countries. Such designation must be
E:\FR\FM\19JAN1.SGM
19JAN1
Agencies
[Federal Register Volume 75, Number 11 (Tuesday, January 19, 2010)]
[Notices]
[Page 2879]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2010-784]
[[Page 2879]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA-2010-N-0020]
Use of Tobacco Marketing Descriptors to Convey Modified Risk;
Request for Comments
AGENCY: Food and Drug Administration, HHS.
ACTION: Notice; request for comments.
-----------------------------------------------------------------------
SUMMARY: The Food and Drug Administration (FDA) is establishing a
public docket to provide an opportunity for interested parties to share
information, research, and ideas on tobacco product marketing
descriptors that may be considered similar to the prohibited terms
``light,'' ``mild,'' and ``low.'' This information will be used to
further FDA's efforts to reduce misleading and deceptive advertising
practices.
DATES: Submit electronic or written comments by February 18, 2010.
ADDRESSES: Submit electronic comments to https://www.regulations.gov.
Submit written comments to the Division of Dockets Management (HFA-
305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061,
Rockville, MD 20852.
FOR FURTHER INFORMATION CONTACT: Kathleen K. Quinn, Center for Tobacco
Products, Food and Drug Administration, 9200 Corporate Blvd.,
Rockville, MD 20850-3229, 240-276-1717, Kathleen.Quinn@fda.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
Tobacco products are responsible for more than 440,000 deaths each
year. The Centers for Disease Control and Prevention report that 70
percent of the 46 million adults who currently smoke in the United
States want to quit. Since the introduction to the American market in
the 1960s of cigarettes marketed as ``light,'' ``low,'' or ``mild,''
millions of smokers have turned to these products in the false belief
that they pose fewer health hazards and may facilitate quitting. While
scientific evidence has demonstrated that light cigarettes do not
reduce the health risks associated with smoking, sales of light
cigarettes have continued to climb, accounting for 92.7 percent of
cigarettes sold in the United States in 2006. Curbing the significant
adverse consequences of tobacco use is one of the most important public
health goals of our time. One step toward the realization of that goal
is to prevent misleading labeling claims and to regulate ``modified
risk'' tobacco products.
On June 22, 2009, the President signed the Family Smoking
Prevention and Tobacco Control Act (the Tobacco Control Act) into law.
The Tobacco Control Act granted FDA important new authority to regulate
the manufacture, marketing, and distribution of tobacco products to
protect the public health generally and to reduce tobacco use by
minors. Among its many provisions, the Tobacco Control Act added
section 911(b) to the Federal Food, Drug, and Cosmetic Act (the act),
banning the manufacture of any tobacco product ``the label, labeling,
or advertising of which uses the descriptors `light', `mild', or `low'
or similar descriptors;'' as of June 22, 2010.
We are requesting comments that will inform the agency's
development of guidance on the meaning of the term ``similar
descriptors.'' A copy of the Tobacco Control Act is available at https://www.fda.gov/tobacco.
II. Request for Comments and Information
Product packaging plays a critical role in fostering brand loyalty
and communicating messages to consumers about the risks and benefits of
product use. FDA is aware that messages of reduced harm can be conveyed
through a variety of visual cues. We are therefore requesting comment
on ways in which descriptors that may be considered similar to
``light,'' ``mild'' and ``low'' used on tobacco product packaging could
impact consumer perceptions of risk. Such descriptors may include:
Adjectives like ``silver,'' ``fine,'' or ``smooth;''
Colors like white, silver or pastels;
Printed numbers associated with risk level;
Letters (e.g., ``L'') or other symbols that connote
``light;''
Depiction of filters or other images that imply
purification or healthfulness;
Words used in brand names that have associations with
potency, risk, or healthfulness; and
Use of terms such as ``natural'' and ``no additives.''
The agency will consider information submitted to the docket in
developing guidance on the meaning of the term ``similar descriptors''
as it pertains to the label, labeling, or advertising of modified risk
tobacco products.
III. Comments
Interested persons may submit to the Division of Dockets Management
(see ADDRESSES) electronic or written comments regarding this document.
Submit a single copy of electronic comments or two paper copies of any
mailed comments, except that individuals may submit one paper copy.
Comments are to be identified by the docket number found in brackets in
the heading of this document. Received comments may be seen in the
Division of Dockets Management between 9 a.m. and 4 p.m., Monday
through Friday.
Dated: January 12, 2010.
David Dorsey,
Acting Deputy Commissioner for Policy, Planning and Budget.
[FR Doc. 2010-784 Filed 1-15-10; 8:45 am]
BILLING CODE 4160-01-S